- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05721014
Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health
Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health Amongst Older Women With High Fracture Risk: A Randomised Controlled Trial
The aim of this clinical trial is to investigate the effect of the OsteoStrong training method and the Individually Adapted and Combined Training on the bone health of older women with high fracture risk. Additionally, the aim is also to explore the participants' experiences of each training method.
Participants will be randomised to either treatment arm A (OsteoStrong) or treatment arm B (Individually Adapted and Combined Training). Participants in both groups will train for nine months. Treatment arm A will train individually once a week and treatment arm B will train in a group twice a week. Both groups will have a training instructor who will supervise and give training instructions.
Researchers will compare the groups to see the effects of the training methods on the participants' bone health among other outcome measures. The participants will be tested at baseline and post-intervention (9 months later).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Stockholms Län
-
Huddinge, Stockholms Län, Sweden, 141 52
- Karolinska Institutet - Department of Neurobiology, Care Sciences and Society: Division of Family medicine and Primary care
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Woman, 65-79 years old.
- Vaccinated against Covid-19.
- Be able to participate in nine months of training.
- Untreated with Osteoporosis-medications, or have an ongoing treatment since at least one year back.
Exclusion Criteria:
- Ongoing treatment with Osteoporosis-medications with an onset within a year, or a previous treatment which was terminated within the last five years.
- Ongoing treatment with Osteoporosis-medications that has been delayed for more than eight months for Denosumab, or more than 18 months for bisphosphonates.
- Vertebral fracture, that have been diagnosed within three months.
- Vertebral fracture or hip fracture, that have not previously been treated with Osteoporosis-medications or been assessed by a physician.
- Bilateral hip replacements.
- Symptomatic disc herniation, inguinal herniation or umbilical herniation.
- Untreated hypertension.
- Other diseases that can affect the results and participation in the study: malignant diseases, muscle dystrophy, secondary osteoporosis, or other conditions that would hinder study participation.
- Ongoing treatment with oral cortisone pills (≥ 5 mg Prednisolone).
- Conditions that hinders the conduction of impact microindentation with OsteoProbe: large edema, skin infection, allergy towards local anaesthetics.
- Ongoing or previous training (within the last year) at OsteoStrong.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: OsteoStrong
Training following the OsteoStrong-method.
|
This training method is an isometric high-impact loading in four different training machines (Spectrum) and balance training on a vibration plate. The four machines are "chest press", "leg press", "pull-down" and "deadlift". The participants press and/or pull isometrically for around 10-15 seconds 1-3 times on every machine. The training session takes around 20 minutes and is performed individually by the participants with the help of a training instructor. |
|
Active Comparator: Individually Adapted and Combined Physical Training
Training based on current recommendations on exercise for people with osteoporosis.
|
This training method is based on the current recommendations on physical activity for people with osteoporosis. The training is divided into two training sessions: Circuit training with ten stations with different exercises for the whole body (strength, balance, endurance, weight-bearing). The participants spend 40 seconds on each station. This is repeated during 40 minutes. The training session starts with a joint warm-up and ends with a cool-down. Strength training with machines for the whole body with the intensity of up to 70-80 % of one repetition max (1RM). The training session starts with a joint warm-up and and a voluntary individual cool-down. The training session takes around 60 minutes and is performed in a group with the help of a training instructor. The participants also have the option to do a home based exercise programme that they could do in a few cases when they were unable to attend the physical group training. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone Material Strength Index (BMSI)
Time Frame: Change from baseline at 9 months
|
Bone Material Strength Index measured with impact microindentation using OsteoProbe
|
Change from baseline at 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone Mineral Density (BMD)
Time Frame: Change from baseline at 9 months
|
Bone Mineral Density and T-score measured with Dual-Energy X-ray Absorptiometry (DXA)
|
Change from baseline at 9 months
|
|
Procollagen Type 1 N-terminal propeptide (S-PINP)
Time Frame: Change from baseline at 3 and 9 months
|
Bone biomarker
|
Change from baseline at 3 and 9 months
|
|
Serum C-telopeptide cross-link type 1 collagen (S-CTX)
Time Frame: Change from baseline at 3 and 9 months
|
Bone biomarker
|
Change from baseline at 3 and 9 months
|
|
Sclerostin
Time Frame: Change from baseline at 3 and 9 months
|
Bone biomarker
|
Change from baseline at 3 and 9 months
|
|
Bone alkaline phosphatase (S-BALP)
Time Frame: Change from baseline at 3 and 9 months
|
Bone biomarker
|
Change from baseline at 3 and 9 months
|
|
Self-rated health questionnaire (SF-36)
Time Frame: Change from baseline at 9 months
|
A questionnaire with multiple choice questions about general health
|
Change from baseline at 9 months
|
|
Falls Efficacy Scale (FES)
Time Frame: Change from baseline at 9 months
|
A questionnaire about self-efficacy and fear of falling, 1-10, where 0 equals "not sure at all" and 10 equals "completely sure".
Higher scores equals better outcome.
|
Change from baseline at 9 months
|
|
Socialstyrelsens questionnaire for lifestyle habits
Time Frame: Change from baseline at 9 months
|
A questionnaire with multiple choice questions about falls and fractures, physical activity, sitting, alcohol and smoking
|
Change from baseline at 9 months
|
|
Numerical Rating Scale (NRS)
Time Frame: Change from baseline at 3 and 9 months
|
A pain rating scale from 0-10, where 0 equals "no pain" and 10 equals "maximum/worst possible pain imaginable".
Higher scores equals worse outcome.
|
Change from baseline at 3 and 9 months
|
|
Back extension strength
Time Frame: Change from baseline at 9 months
|
Measuring back extension strength with Digimax
|
Change from baseline at 9 months
|
|
Grip strength
Time Frame: Change from baseline at 9 months
|
Measuring grip strength with hand dynamometer (JAMAR)
|
Change from baseline at 9 months
|
|
Chair stand test
Time Frame: Change from baseline at 9 months
|
5 seconds, 30 seconds and time for making 50 chair stands
|
Change from baseline at 9 months
|
|
Back extension endurance
Time Frame: Change from baseline at 9 months
|
Measuring back extension endurance with Sörensen's test
|
Change from baseline at 9 months
|
|
Static sit-up
Time Frame: Change from baseline at 9 months
|
Sitting with the upper body in 45 degrees
|
Change from baseline at 9 months
|
|
Lung capacity
Time Frame: Change from baseline at 9 months
|
Lung capacity measured with dynamic spirometry (Welch Allyn)
|
Change from baseline at 9 months
|
|
One leg standing (eyes open)
Time Frame: Change from baseline at 9 months
|
Balance test
|
Change from baseline at 9 months
|
|
One leg standing (eyes closed)
Time Frame: Change from baseline at 9 months
|
Balance test
|
Change from baseline at 9 months
|
|
Two leg standing on a straight line (eyes open)
Time Frame: Change from baseline at 9 months
|
Balance test
|
Change from baseline at 9 months
|
|
Two leg standing on a straight line (eyes closed)
Time Frame: Change from baseline at 9 months
|
Balance test
|
Change from baseline at 9 months
|
|
Walking forward on a straight line
Time Frame: Change from baseline at 9 months
|
Balance test
|
Change from baseline at 9 months
|
|
Walking backwards between to lines
Time Frame: Change from baseline at 9 months
|
Balance test
|
Change from baseline at 9 months
|
|
BtrackS
Time Frame: Change from baseline at 9 months
|
Balance test, measuring body sway, standing on a platform with both legs together, arms crossed and eyes closed.
|
Change from baseline at 9 months
|
|
Accelerometry
Time Frame: Change from baseline at 9 months
|
Accelerometers worn around the waist to measure physical activity levels for up to nine days.
|
Change from baseline at 9 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Helena Salminen, Ass. prof., Karolinska Institutet
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-04359 Osteostrong
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.